Počet záznamov: 1
inotuzumab ozogamicín
SYS d000080045 LBL 00000nx^^^2200181-^^45^^ 005 20240119195338.4 100 $a 20200101asloy0103 ba0 152 $b mesh 250 $a inotuzumab ozogamicín $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2020 (2004) $8 eng 330 1-
$a Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC). $8 eng 450 $a Besponsa $5 e $8 eng 450 $a Besponsa $5 e $8 slo 686 $a D09.408.051.247.750 686 $a D12.776.124.486.485.114.224.060.794 686 $a D12.776.124.790.651.114.224.060.794 686 $a D12.776.377.715.548.114.224.200.794 750 $a Inotuzumab Ozogamicin $8 eng 801 -0
$a SK $b BA006 $c 20200216 801 -2
$a SK $b BA006 $c 20200427 980 $x M
Počet záznamov: 1